v3.26.1
Stockholders' Equity (Deficit) - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Apr. 13, 2026
Dec. 22, 2025
Dec. 17, 2025
Jun. 30, 2026
Jun. 30, 2026
Dec. 31, 2025
Subsidiary, Sale of Stock [Line Items]            
Common stock, shares authorized       300,000,000 300,000,000 300,000,000
Common stock, par value       $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, shares authorized       10,000,000 10,000,000 10,000,000
Preferred stock outstanding       0 0 0
Preferred stock issued       0 0 0
Preferred stock, par or stated value per share       $ 0.0001 $ 0.0001 $ 0.0001
Issuance of common stock upon exercise of pre-funded warrants, Shares 799,987          
Deferred transaction costs       $ 514,000 $ 514,000 $ 0
Securities Purchase Agreement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Net proceeds from issuance of private placement   $ 46,600,000        
Issuance costs   3,400,000        
Pre-Funded Warrants            
Subsidiary, Sale of Stock [Line Items]            
Pre-Funded Warrant Notice Period     61 days      
Warrants exercised date         Apr. 13, 2026  
Warrants outstanding       0 0  
Pre-Funded Warrants | Securities Purchase Agreement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Common stock shares issued     800,000      
Purchase price per share     $ 9.9999      
Exercise Price per Share     $ 0.0001      
Net proceeds from issuance of private placement     $ 8,000,000      
Private Placement [Member] | Securities Purchase Agreement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Common stock shares issued     4,200,000      
Purchase price per share     $ 10      
Aggregate gross proceeds of common stock     $ 42,000,000      
December Two Thousand Twenty Five Private Placement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Aggregate gross proceeds of common stock   $ 50,000,000        
Maximum | At-the-Market Offering            
Subsidiary, Sale of Stock [Line Items]            
Sale of securities, offering price $ 350,000,000          
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Issuance of common stock upon exercise of pre-funded warrants, Shares       799,987    
Common Stock | Pre-Funded Warrants            
Subsidiary, Sale of Stock [Line Items]            
Shares outstanding percentage     19.99%      
Common Stock | At-the-Market Offering            
Subsidiary, Sale of Stock [Line Items]            
Common stock shares issued         0  
Aggregate compensation payable percentage 3.00%          
Sale of stock, effective Date Apr. 13, 2026          
Deferred transaction costs       $ 500,000 $ 500,000  
Common Stock | Minimum | Pre-Funded Warrants            
Subsidiary, Sale of Stock [Line Items]            
Shares outstanding percentage     4.99%      
Common Stock | Maximum | Pre-Funded Warrants            
Subsidiary, Sale of Stock [Line Items]            
Shares outstanding percentage     9.99%      
Common Stock | Maximum | At-the-Market Offering            
Subsidiary, Sale of Stock [Line Items]            
Sale of stock, offering price $ 100,000,000